on behalf of the ASSERT (Aortic Stentless versus Stented valve assessed by Echocardiography Randomized Trial) InvestigatorsBackground-Aortic valve replacement (AVR) is the established treatment for severe aortic stenosis. In response to the long-term results of aortic homografts, stentless porcine valves were introduced as an alternative low-resistance valve.We conducted a randomized trial comparing a stentless with a stented porcine valve in adults with severe aortic stenosis. Methods and Results-The primary outcome was change in left ventricular mass index (LVMI) measured by transthoracic echocardiography and, in a subset, by cardiovascular MR. Measurements were taken before valve replacement and at 6 and 12 months. Patients undergoing AVR with an aortic annulus Յ25 mm in diameter were randomly allocated to a stentless (nϭ93) or a stented supra-annular (nϭ97) valve. There were no significant differences in mean LVMI between the stentless versus stented groups at baseline (176Ϯ62 and 182Ϯ63 g/m 2 , respectively) or at 6 months (142Ϯ49 and 131Ϯ45 g/m 2 , respectively), although within-group changes from baseline to 6 months were highly significant. Changes in LVMI measured by cardiovascular MR (nϭ38) were consistent with the echo findings. There was a greater reduction in peak aortic velocity (PϽ0.001) and a greater increase in indexed effective orifice area (PϽ0.001) in the stentless group than in the stented group. There were no differences in clinical outcomes between the 2 valve groups. Conclusions-Despite significant differences in indexed effective orifice area and peak flow velocity in favor of the stentless valve, there were similar reductions in left ventricular mass at 6 months with both stented and stentless valves, which persisted at 12 months. (Circulation. 2005;112:2696-2702.)